Artificial Intelligence-based Ocular Motor Biomarkers of Neurologic Disease
Description
This presentation will explore AI-driven ocular motor biomarkers for non-invasive neurologic disease screening, diagnosis, monitoring, and treatment.
Date: September 15, 2025
Time: 4:15 pm to 5:45 pm
Track: Traditional Special Interest Group (SIG)
Neuro-ophthalmologists and neuro-otologists study and treat complex neurologic diseases that impact the visual and vestibular systems. Both fields rely heavily on precise neurologic examination as well as accurate interpretation of specialized diagnostic testing, skills that often seem intimidating for the neurologist given lack of uniform didactic exposure during training. In this Special Interest Group session, leaders in the fields of neuro-ophthalmology and neuro-otology will present cutting-edge research on the diagnosis and management of neuro-ophthalmic and neuro-vestibular disease. Speakers will highlight the advent of technologies such as generative artificial intelligence and optical coherence tomography in the evaluation of adult and pediatric neurologic conditions including central vision loss, nystagmus, and optic neuritis. By the completion of this session, participants will understand the role of emerging technologies to diagnose and manage neuro-ophthalmic and neuro-vestibular disease.
At the conclusion of this session, attendees should be able to:
This presentation will explore AI-driven ocular motor biomarkers for non-invasive neurologic disease screening, diagnosis, monitoring, and treatment.
This presentation will focus on the use of generative AI to measure visual function in children with cerebral and cortical visual impairment (CVI).
This presentation will be a discussion of the inclusion of optic nerve topography in the revised diagnostic criteria of multiple sclerosis.